Analytically Sensitive Rickettsia Species Detection for Laboratory Diagnosis

Area of Science:

• Molecular Biology
• Infectious Diseases
• Clinical Diagnostics

Background:

• Diagnosing rickettsial diseases is difficult due to vague symptoms and low bacterial levels in early illness.
• Prompt doxycycline treatment is crucial, especially for Rocky Mountain spotted fever, highlighting the need for sensitive diagnostics.

Purpose of the Study:

• To develop and validate a highly sensitive real-time reverse transcriptase polymerase chain reaction (PCR) assay, named RCKr, for detecting Rickettsia species DNA in human clinical samples.

Main Methods:

• Development and validation of the RCKr real-time PCR assay.
• Determination of the limit of detection (LOD) and comparison with the PanR8 assay.
• Evaluation of RCKr performance using 49 banked clinical samples.

Main Results:

• The RCKr assay demonstrated a limit of detection of 20 genomic copies/mL, a 100-fold improvement over the PanR8 assay (1,800–2,000 gc/mL).
• RCKr correctly identified 35 of 49 previously positive samples and detected two additional clinically suspected cases missed by PanR8.
• Analytical specificity and sensitivity for Rickettsia detection were high.

Conclusions:

• The RCKr assay offers significantly enhanced analytical sensitivity and specificity for Rickettsia detection compared to existing methods.
• RCKr shows promise for improving the early diagnosis of rickettsial diseases, potentially leading to more timely and effective treatment.